BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioMidwest

  Beating back pain in dogs: Researchers to test new use for shockwave therapy to bring relief

  Dogs with chronic lower back pain could eventually find relief from a treatment that already exists.

  February 24, 2021

   · 

  3 min read
• Drug Development

  Opthea Finalizes Study Designs and Start-up Activities for Phase 3 Pivotal Clinical Trials of OPT-302 in Wet AMD

  Following consultations with US FDA and EU EMA, two pivotal Phase 3 clinical trial designs are finalized to assess 2 mg OPT-302 administered 4-weekly or 8-weekly in combination with Lucentis® (ShORe study) and Eylea® (COAST study) standard of care

  February 24, 2021

   · 

  9 min read
• Deals

  Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies

  Synthetic circular RNA (oRNA) combines nature-driven insights with rational design to produce a bold new class of RNA therapeutics

  February 24, 2021

   · 

  4 min read
• Drug Development

  Alzheon CEO Presents Overview of Oral Anti-Amyloid ALZ-801 Phase 3 Program at 9th Neurodegenerative Drug Development Summit

  Dr. Martin Tolar to Provide an Update on Alzheon’s ALZ-801 Phase 3 Program and Join Panel Discussion on Current Research in Alzheimer’s Disease

  February 24, 2021

   · 

  6 min read
• Business

  United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 Financial Results

  United Therapeutics Corporation announced its financial results for the fourth quarter and year ended December 31, 2020.

  February 24, 2021

   · 

  26 min read
• Demand for Articular Defects Treatment Bolstered by Surging Microfracture Procedure, Says Fact.MR

  Fact.MR, a global research & consulting firm, in their updated edition of the report, indicated that the Articular Defects Treatment market is poised to record a steady growth pace over the years to come.

  February 24, 2021

   · 

  4 min read
• Business

  CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health

  CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a long-term, multi-year agreement with CHRISTUS Health, a Texas-based health system, to provide a broad spectrum of technology-enabled services in radiation oncology.

  February 24, 2021

   · 

  4 min read
• Deals

  Probo Medical Acquires IMAX Medical

  Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced today the acquisition of IMAX Medical (“IMAX”).

  February 24, 2021

   · 

  2 min read
• Biotech Beach

  AppliedVR Completes Pivotal Trial Finding Virtual Reality Is a Holistic Treatment for Chronic Pain

  AppliedVR, a pioneer advancing the next generation of digital medicine, today announced results from its pivotal randomized controlled trial (RCT), evaluating virtual reality (VR) therapy for treating chronic pain at home.

  February 24, 2021

   · 

  6 min read
• Genetown

  Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences

  Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences

  February 24, 2021

   · 

  2 min read